BSE · 531592
Genpharmasec Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹51 Cr with net profit ₹3 Cr — a 5.06% net margin, versus 3.51% the period before.
Shareholding
As of 2026-09-30
- Promoter32.06%
- Public67.94%
99,856 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.16× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Trading · ranked #261 of 688 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,71,625 Cr | 103.62 | 3.78 | 3.66% | 4.59% |
| Avenue Supermarts Limited | ₹2,23,416 Cr | 71.68 | 8.56 | 11.94% | 4.2% |
| Trent Ltd. | ₹1,64,182 Cr | 85.72 | 21.1 | 24.4% | 8.62% |
| FSN E-Commerce Ventures Ltd. | ₹1,01,123 Cr | 304.31 | 60.95 | 19.49% | 2.85% |
| Aditya Infotech Limited | ₹50,682 Cr | 106.18 | 13.81 | 16.16% | 10.38% |
| Vishal Mega Mart Limited | ₹44,037 Cr | 48.96 | 5.58 | 11.37% | 6.45% |
| Premier Energies Limited | ₹40,402 Cr | 22.83 | 7.85 | 34.23% | 19.11% |
| Aegis Logistics Limited | ₹40,053 Cr | 30.06 | 6.01 | 20.01% | 14.99% |
| Redington Limited | ₹25,603 Cr | 12.76 | 2.38 | 18.62% | 1.31% |
| Honasa Consumer Limited | ₹15,206 Cr | 60.26 | 10.75 | 19.03% | 10.3% |
| Genpharmasec Limited(this company) | ₹61 Cr | 27.5 | 0.9 | 3.2% | 0.94% |
AI analysis
AI-generated · google/gemini-2.5-flashGenpharmasec Limited does not have specified business activities. The company reported a market capitalization of Rs 58 Cr. Its revenue stood at Rs 36.78 Cr with a profit margin of 31.4%.
Positives
- +The company has a low debt-to-equity ratio of 0.07.
- +The Return on Equity (ROE) is significantly high at 242%.
- +The company recorded a profit margin of 31.4%.
Negatives
- −Promoter holding is relatively low at 29.9792%.
- −Return on Capital Employed (ROCE) is low at 2.1844%.
- −The company experienced negative net profit in December 2025 (-Rs 0.83 Cr) and September 2025 (-Rs 1.18 Cr).
Financial Performance
For the fiscal year ending March 2025, Genpharmasec Limited reported revenue of Rs 36.784 Cr and a net profit of Rs 1.2312 Cr. Quarterly revenue for March 2026 was Rs 55.43 Cr, with a net profit of Rs 1.23 Cr. Over the past four quarters, revenue fluctuated, with a high of Rs 55.43 Cr in March 2026 and a low of Rs 8.48 Cr in December 2024.
Profitability & Returns
Genpharmasec Limited achieved a profit margin of 31.4%. The company's Return on Capital Employed (ROCE) was 2.1844% and Return on Equity (ROE) was 242%. Earnings per share (EPS) for the fiscal year ending March 2025 was Rs 0.02. The PE ratio for the company is 35.
Balance Sheet
The company's debt-to-equity ratio is 0.07, indicating a low level of debt relative to its equity. The book value per share is Rs 1.2.
Ownership & Pledges
As of June 30, 2026, promoter holding in Genpharmasec Limited stood at 29.9792%, while public shareholding was 70.0208%. There is no pledged promoter holding. The number of shareholders was 101,134.
Regulatory & Surveillance
There is no information available regarding any surveillance measures on Genpharmasec Limited.
Data as of — price: 2026-11-07 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.